ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Every merger & restructuring announcement on NSE and BSE that our alert engine sent, newest first. Each one has its own page with the summary, the key figures and the original filing.
Time
3,558 announcements
Gujarat Gas Limited announced that its Composite Scheme of Arrangement became effective on May 1, 2026. The restructuring involves the amalgamation of GSPC, GSPL, and GEL into the company, and the demerger of the Gas Transmission Business into GSPL Transmission Limited.
R Systems International Limited announced the effectiveness of its merger with Velotio Technologies and Scaleworx Technologies following NCLT approval. The merger became effective on May 1, 2026. Consequently, the company's authorised share capital has been increased to ₹20.70 Crore, and the Transferor companies stand dissolved without winding up.
Indoco Remedies Limited has agreed to sell its Ophthalmic Division to Sunways (India) Private Limited for ₹110 Crore. The cash transaction is a slump sale aimed at focusing on core therapeutic areas. The division contributed approximately 3.2% to the company's standalone revenue for FY 2024-2025.
Bajaj Consumer Care Limited has announced that the Scheme of Arrangement with Vishal Personal Care Limited became effective on May 1, 2026. This follows the receipt of the NCLT Jaipur Bench order and subsequent filing with the Registrar of Companies. The demerger aims to restructure the company's personal care business segments.
Mahindra & Mahindra's subsidiary, MEAL, allotted equity shares to BII and Temasek upon conversion of CCPS valued at ₹40,425 Crore. This transaction dilutes M&M's stake in MEAL from 99.99% to 92.45%, though it remains a subsidiary.
Hubtown Limited has issued a notice for an NCLT-convened meeting on June 5, 2026, to approve the merger of Saicharan Consultancy Private Limited into the company. The amalgamation will be executed via a Scheme of Arrangement subject to shareholder and regulatory approvals.
Procter & Gamble Health Limited has executed a sale agreement for immovable properties in Mumbai. The transaction is expected to generate a profit of approximately ₹32 Crore for the company.
Hubtown Limited has convened a meeting of its equity shareholders on June 05, 2026, to approve the merger of Saicharan Consultancy Private Limited into the company. The strategic amalgamation aims to consolidate ownership in its subsidiary, Rare Townships Private Limited, and achieve operational efficiencies.
National Securities Depository Ltd (NSDL) approved its subsidiary, NSDL Database Management Limited (NDML), to incorporate a new subsidiary. NDML will transfer its Insurance Repository Business to this new entity, subject to regulatory approvals.
Samvardhana Motherson International Limited has incorporated Motherson Digital Technologies Limited as a new wholly owned subsidiary in India. The subsidiary, with an initial share capital of ₹0.10 Crore, will focus on software development and IT solutions.
Mobavenue AI Tech Limited incorporated a new step-down subsidiary, Mobavenue LLC, in Delaware, USA, on March 20, 2026. The new entity, with an initial capital of 100 USD, aims to expand the company's digital advertising and technology solution offerings in the United States market as part of its organic growth strategy.
Indoco Remedies is selling its Ophthalmic Division in India and several African territories to Sunways (India) Private Limited for ₹110 Crore. The transaction, executed via a slump sale, is expected to conclude within three months. This strategic divestment allows the company to focus on its core therapeutic areas.
Indoco Remedies Limited approved the strategic transfer of its ophthalmic division in India and select African territories to Sunways (India) Private Limited. The divestment allows Indoco to focus on core therapeutic areas while Sunways strengthens its specialized ophthalmology platform. The transaction includes an established operating portfolio and manufacturing capabilities.
Power Finance Corporation Limited has incorporated five wholly owned subsidiaries through its subsidiary, PFC Consulting Limited. These Special Purpose Vehicles (SPVs) will develop specific independent transmission projects in Gujarat, Andhra Pradesh, and Tamil Nadu. The SPVs will eventually be transferred to successful bidders selected through a tariff-based competitive bidding process.
Samvardhana Motherson International Limited incorporated a new wholly owned subsidiary, Motherson Digital Technologies Limited, on April 30, 2026. The new entity, with an initial share capital of ₹0.10 Crore, will focus on information technology services, including software development and digital solutions.
Indoco Remedies approved the slump sale of its Ophthalmic Division to Sunways (India) Private Limited for ₹110 Crore. The transaction covers territories including India and several African nations. The deal, representing 3.2% of Indoco's standalone revenue, is expected to conclude within three months as the company focuses on core therapeutic areas.
Aeroflex Enterprises Limited completed the sale of its 68% stake in M.R. Organisation Limited to Ingersoll-Rand Industrial US, Inc. for ₹222.87 Crore. Consequently, MRO has ceased to be a subsidiary. The transaction marks a significant milestone, providing the company with substantial proceeds to maximize long-term shareholder value.
GHV Infra Projects Limited approved the incorporation of a wholly owned subsidiary in Ohio, USA. This strategic expansion aims to enhance overseas operations and evaluate infrastructure opportunities in the United States.
Dr. Lal Path Labs Ltd. is incorporating a new wholly owned subsidiary in Dubai, UAE, named Dr. Lal PathLabs FZCO. The subsidiary will focus on diagnostic services and allied activities, including potential acquisitions and joint ventures in the region. The investment will be made at face value subject to regulatory approvals.
Action Construction Equipment Limited is transferring its Heavy Cranes Business to its JV, ACE KATO Private Limited, on a slump sale basis. The division contributed ₹85.77 Crore (2.58%) to FY25 revenue. The transaction is expected to conclude by June 30, 2026, with consideration settled through the issuance of subscription shares by the JV company.
Laurus Labs Ltd has approved the voluntary closure of its non-material German subsidiary, Laurus Generics GmbH. The subsidiary reported nil turnover for FY 2025-26 and its closure is expected to have no material impact on the company's consolidated financials.
Laurus Labs approved an additional investment of approximately ₹107.80 Crore (EURO 9.8 million) in its joint venture, KRKA Pharma Private Limited. The funds will support KRKA's capital expenditure for setting up a manufacturing facility. The company's shareholding in the JV will remain unchanged at 49%.
Laurus Labs approved an investment of approximately ₹107.80 Crore (EURO 9.8 million) in its joint venture, KRKA Pharma Private Limited. The funds will support the setup of a manufacturing facility. Additionally, the company announced two independent director appointments and the voluntary closure of its step-down German subsidiary.
Cyient Ltd issued a clarification regarding its proposed equity share buyback. The company corrected a statement regarding US security registration and confirmed it will seek exemptive relief from the US SEC for tender offer procedures due to conflicting regulatory requirements between Indian and U.S. laws.
Zydus Lifesciences Limited, through its subsidiary Zydus Worldwide DMCC, incorporated a new wholly owned subsidiary named Zara Merger SUB Inc. in the USA on April 24, 2026. The new entity belongs to the pharmaceutical industry. There was no cash consideration for the incorporation.
Larsen & Toubro (L&T) has signed an agreement to divest its 100% stake in L&T Metro Rail (Hyderabad) Limited to Hyderabad Metro Rail Limited (HMRL). The move aligns with L&T’s strategy to exit non-core development projects and unlock capital for its engineering and technology businesses. HMRL plans to further expand the 69 km metro network.
Zydus Lifesciences incorporated a new wholly owned subsidiary, Zara Merger SUB Inc., in the United States on April 24, 2026. The entity is part of an internal group restructuring within the pharmaceutical industry. The subsidiary has not yet commenced business operations and currently reports nil turnover.
Bajaj Auto Limited has scheduled a Board meeting for May 06, 2026, to consider a proposal for the buyback of its fully paid-up equity shares. Trading window for designated persons remains closed until May 08, 2026.
LGB Forge Limited executed a Sale Deed on April 29, 2026, to sell 7.36 acres of land in Coimbatore to LGB Educational Foundation for ₹12 Crore. The transaction, involving a related party trust, was conducted at arm's length following shareholder approval via postal ballot. This asset sale contributes significantly to the company's liquidity.
Sun Pharma Advanced Research Company Ltd (SPARC) has agreed to sell its FDA-granted Priority Review Voucher for US $195 million (₹1833.00 Crore). The transaction, subject to customary closing conditions and HSR antitrust clearance, will provide significant capital to accelerate SPARC's internal pipeline development and strengthen its innovation strategy.